1. Shin HC, Gu MJ, Kim SW, Kim JW, Choi JH. Coexistence of gastrointestinal stromal tumor and inflammatory myofibroblastic tumor of the stomach presenting as a collision tumor: first case report and literature review. Diagnostic pathology. 2015;10(1):181.
2. Buchner D, Hieggelke L, Löser H, Bruns CJ, Quaas A, Ghadimi MPH. First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: a case report. BMC cancer. 2018;18(1):1243-.
3. Damasena IL, and R. Carey-Smith. Retroperitoneal Schwannoma With Monoclonal Plasma Cell Infiltration. International Journal of Surgical Pathology. Dec. 2012;vol. 21(no. 6):pp. 635–8.
4. Miettinen M, Felisiak-Golabek A, Wang Z, Inaguma S, Lasota J. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases. The American journal of surgical pathology. 2017;41(5):577-85.
5. Laroia ST, Yadav T, Rastogi A, Sarin S. Malignant Retroperitoneal Extra-Gastrointestinal Stromal Tumor: A Unique Entity. World journal of oncology. 2016;7(2-3):45-50.
6. Miettinen M, Lasota J. Histopathology of gastrointestinal stromal tumor. Journal of surgical oncology. 2011;104(8):865-73.
7. Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. The American journal of surgical pathology. 2009;33(9):1401-8.
8. Ryu KH, Im CM, Kim MK, et al. Inflammatory myofibroblastic tumor of the kidney misdiagnosed as renal cell carcinoma. Journal of Korean medical science. 2010;25(2):330-2.
9. Koirala R, Shakya VC, Agrawal CS, et al. Retroperitoneal inflammatory myofibroblastic tumor. The American Journal of Surgery. 2010;199(2):e17-e9.
10. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. The American journal of surgical pathology. 1995;19(8):859-72.
11. Attili SVS, Chandra CR, Hemant DK, Bapsy PP, RamaRao C, Anupama G. Retroperitoneal inflammatory myofibroblastic tumor. World journal of surgical oncology. 2005;3:66-.
12. Marino-Enriquez A, Wang WL, Roy A, et al. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. The American journal of surgical pathology. 2011;35(1):135-44.
13. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. The American journal of surgical pathology. 2007;31(4):509-20.
Retroperitoneal yerleşimli ekstra-gastrointestinal stromal tümör ve inflamatuar myofibroblastik tümör birlikteliğinde ilk kollizyon tümörü
Year 2020,
Volume: 45 Issue: 4, 1868 - 1871, 27.12.2020
1. Shin HC, Gu MJ, Kim SW, Kim JW, Choi JH. Coexistence of gastrointestinal stromal tumor and inflammatory myofibroblastic tumor of the stomach presenting as a collision tumor: first case report and literature review. Diagnostic pathology. 2015;10(1):181.
2. Buchner D, Hieggelke L, Löser H, Bruns CJ, Quaas A, Ghadimi MPH. First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: a case report. BMC cancer. 2018;18(1):1243-.
3. Damasena IL, and R. Carey-Smith. Retroperitoneal Schwannoma With Monoclonal Plasma Cell Infiltration. International Journal of Surgical Pathology. Dec. 2012;vol. 21(no. 6):pp. 635–8.
4. Miettinen M, Felisiak-Golabek A, Wang Z, Inaguma S, Lasota J. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases. The American journal of surgical pathology. 2017;41(5):577-85.
5. Laroia ST, Yadav T, Rastogi A, Sarin S. Malignant Retroperitoneal Extra-Gastrointestinal Stromal Tumor: A Unique Entity. World journal of oncology. 2016;7(2-3):45-50.
6. Miettinen M, Lasota J. Histopathology of gastrointestinal stromal tumor. Journal of surgical oncology. 2011;104(8):865-73.
7. Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. The American journal of surgical pathology. 2009;33(9):1401-8.
8. Ryu KH, Im CM, Kim MK, et al. Inflammatory myofibroblastic tumor of the kidney misdiagnosed as renal cell carcinoma. Journal of Korean medical science. 2010;25(2):330-2.
9. Koirala R, Shakya VC, Agrawal CS, et al. Retroperitoneal inflammatory myofibroblastic tumor. The American Journal of Surgery. 2010;199(2):e17-e9.
10. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. The American journal of surgical pathology. 1995;19(8):859-72.
11. Attili SVS, Chandra CR, Hemant DK, Bapsy PP, RamaRao C, Anupama G. Retroperitoneal inflammatory myofibroblastic tumor. World journal of surgical oncology. 2005;3:66-.
12. Marino-Enriquez A, Wang WL, Roy A, et al. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. The American journal of surgical pathology. 2011;35(1):135-44.
13. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. The American journal of surgical pathology. 2007;31(4):509-20.
Astarcı, Hesna Müzeyyen and Nur Tunç. “Retroperitoneally Located First Collision Tumor of Extra-Gastrointestinal Stromal Tumor and Inflamatuar Myofibroblastic Tumor”. Cukurova Medical Journal, vol. 45, no. 4, 2020, pp. 1868-71, doi:10.17826/cumj.791505.